Malignant hyperthermia is a rare diagnosis, but nonetheless one worth being aware of. Very rarely, malignant hyperthermia may be triggered by succinylcholine, causing it to present initially in the emergency department or ICU. Far more often, malignant hyperthermia will be diagnosed in the operating room – with intensivists involved in providing follow-up care.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
Latest posts by Josh Farkas (see all)
- PulmCrit Hot Take: Steroid for severe pneumonia (CAPE COD trial) - March 21, 2023
- PulmCrit Blogitorial – SIESTA syndrome: Sedation Induced EEG Suppression with Transient Agitation - December 19, 2022
- PulmCrit Hot Take – Acetazolamide plus furosemide for decongestion of heart failure (ADVOR trial) - August 27, 2022
Hi Josh, a few points to add for MH in the operating theatre:
– while implied by your point about hyperventilation, it is probably worth saying explicitly to turn off the volatile anaesthetic and remove the vaporisers
– as a corollary to this, you will often need to give a TIVA anaesthetic if surgery can’t be ceased urgently
– mixing dantrolene is hard work and will require multiple people assigned to this
– in Australia and NZ, a task card system (http://malignanthyperthermia.org.au/mh-task-cards/) is commonly included in the MH box/cart. This is an invaluable resource for team management in these crises